Roche Upbeat On Ocrevus Despite Consensus Miss

COVID-19 And Competition Slows Growth

Pathway
Patients unwilling to change treatment pathways in the pandemic • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Neurological

More from Therapy Areas